Free shipping on all orders over $ 500
About 30 results found for searched term "ATPase" (0.015 seconds)
| Cat.No. | Name | Information |
|---|---|---|
| M2093 | Enoxacin | Enoxacin is a small molecule inhibitor of binding between the B2-subunit of vacuolar H+-ATPase (V-ATPase) and microfilaments. |
| M2294 | Brefeldin A | Brefeldin A is a lactone antibiotic and ATPase inhibitor for protein transport with IC50 of 0.2 μM in HCT 116 cells. Brefeldin A is also an autophagy and mitophagy inhibitor. Brefeldin A is a CRISPR/Cas9 activator. Brefeldin A inhibits HSV-1 and has anti-cancer activity. |
| M2459 | Blebbistatin | Blebbistatin is a cell-permeable inhibitor for non muscle myosin II ATPase with IC50 of ~2 μM, does not inhibit myosin light chain kinase, inhibits contraction of the cleavage furrow without disrupting mitosis or contractile ring assembly. *The compound is unstable in solutions, freshly prepared is recommended |
| M2474 | BTB06584 | BTB06584 is an IF1-dependent, selective inhibitor of the mitochondrial F1 Fo-ATPase. |
| M2904 | Ouabain | Ouabain is a selective Na+/K+, -ATPase inhibitor, binds to α2 /α3 subunit with Ki of 41 nM/15 nM. |
| M3449 | PF-3716556 | PF 3716556 is a potent and selective P-CAB (potassium-competitive acid blocker), with pIC50 of 6.026 and 7.095 for the inhibition of porcine H+,K+-ATPase activity in ion-leaky and ion-tight assay, respectively, inhibits gastric acid secretion, displays no activity at Na+ |
| M3696 | Rostafuroxin | Rostafuroxin, a novel antihypertensive compound, acts as a selective inhibitor of srC-SH2 interaction with Na, K-ATPase activated by mutated adducin and Wabin in vivo. |
| M3707 | Rabeprazole Sodium | Rabeprazole is a frequently used second-generation proton pump inhibitor (PPI) that irreversibly inactivates gastric H+/K+-ATPase. |
| M3987 | Ginsenoside Rb1 | Ginsenoside Rb1 is an ingredient in the Chinese medicine Panax ginseng. Ginsenoside inhibition Na, K-ATPase++ activityIC50 6.3±1.0 μM. Ginsenoside Rb1 also inhibits IRAK-1 activation and phosphorylation of NF-κB p65. |
| M4339 | Bufalin | Bufalin is a potent Na+/K+-ATPase inhibitor, binds to the subunit α1, α2 and α3, with Kd of 42.5, 45 and 40 nM respectively, it has anti-cancer activity. |
| M4765 | Oleandrin | Oleandrin (PBI-05204) inhibited Na+, K+ -atPase activity with IC50 of 620 nM. |
| M4953 | Bafilomycin A1 | Bafilomycin A1 (BafA1) is a vacuolar H+-ATPase inhibitor with IC50 of 0.44 nM. |
| M5161 | Sodium orthovanadate | Sodium orthovanadate is an alkaline phosphatase and (Na,K)-ATPase inhibitor with IC50 of 10 μM. |
| M5285 | Ilaprazole | Ilaprazole, a substituted benzimidazole, is a new candidate drug that is an H+ /K+ ATPase inhibitor designed for the treatment of gastric ulcers. |
| M5409 | Amiodarone | Amiodarone HCl is a sodium/potassium-ATPase inhibitor and an autophagy activator, used to treat various types of cardiac dysrhythmias. |
| M5633 | Pantoprazole sodium | Pantoprazole is a proton pump inhibitor drug that inhibits gastric acid secretion. It works on gastric parietal cells to irreversibly inhibit (H+/K+)-ATPase function and suppress the production of gastric acid. |
| M9118 | Chebulinic acid | Chebulinic acid is a potent natural inhibitor of M. tuberculosis DNA gyrase, also can inhibit SMAD-3 phosphorylation, inhibit H+ K+-ATPase activity. |
| M6194 | Esomeprazole Magnesium trihydrate | Esomeprazole Magnesium trihydrate is a proton pump inhibitor which reduces acid secretion through inhibition of the H+ / K+ ATPase in gastric parietal cells. |
| M6501 | BHQ | BHQ is a inhibitor of SERCA ATPase. |
| M6973 | ML 240 | ML 240 is a aTP-competitive inhibitor of p97 ATPase. |
| M7103 | Paxilline | Paxilline is a sERCA ATPase blocker. Also potent BK Ca channel blocker. |
| M7280 | SCH 28080 | SCH 28080 is a h +,K +-ATPase inhibitor. |
| M7409 | Thapsigargin | Thapsigargin is a potent inhibitor of SERCA ATPase. |
| M7575 | Apoptozole | Apoptozole is an inhibitor of the ATPase domain of Hsc70 and Hsp70, with Kds of 0.21 and 0.14 μM, respectively, and can induce apoptosis. |
| M7624 | 2,3-Butanedione monoxime | 2,3-Butanedione Monoxime (BDM) is a myosin ATPASE inhibitor. 2,3-Butanedione Monoxime is a skeletal and cardiac muscle contraction inhibitor. 2,3-Butanedione monoxime induces sarcoplasmic reticulum Ca2+ release. |
| M7732 | CGP-37157 | Specific inhibitor of mitochondrial Na+/Ca2+ exchange as well as sarcoplasmic reticulum calcium-stimulated ATPase and possibly other calcium channels. |
| M7737 | Concanamycin A (Folimycin) | Concanamycin A (Folimycin) is a macrolide antibiotic and a specific vacuolar type H+-ATPase (V-ATPase) inhibitor. |
| M7980 | Ouabain octahydrate | Cardiac glycoside, inhibits Na(+)/K(+) ATPase, regulates transcription of MDR (increase, Pgp) and MRP (increase MRP1 and decrease CFTR, cyctic fibrosis transport receptor or cAMP-activated Cl- channel) genes, also alters localization of MRP1. |
| M8185 | Strophanthidin | Strophanthidin is a cardiotonic steroid that elevates the activity of Na+/K+-ATPase in cardiac myocytes. |
| M8318 | KM91104 | KM91104 is a cell-permeable vacuolar ATPases (V-ATPase) inhibitor that specifically targets the V-ATPase a3-B2 subunits interaction. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.
